Shift4 Payments FOUR 深 沪
已收盘 10-02 16:00:00 美东时间
36.17
+0.590
+1.66%
华盛通- 最 高36.80
- 今 开35.79
- 成交量 180.36万股
- 最 低 35.28
- 昨 收 35.58
- 总市值 285.60万
- 52周最高 78.61
- 市盈率 静 33.52
- 换手率 2284.20%
- 52周最低 34.56
- 委 比 -56.10%
- 总股本 7.90万
- 历史最高 127.50
- 量 比 0.75
- 振 幅 4.27%
- 历史最低 29.39
- 每 手 1
- 风险率 12.14%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Shift4 Payments, Inc. 6 SER A CNV PREF declares $1.50 dividend
Shift4 Payments, Inc. 6 SER A CNV PREF (FOUR.PR.A) declares $1.50/share quarterly dividend, in line with previous. Forward yield 12.02% Payable Nov. 2; for shareholders of record Oct. 15; ex-div Oct. ...
10-03 05:05
NASA Administrator Jared Isaacman Hails Elon Musk’s SpaceX Starship Orbital Launch—Says NASA Is ‘Excited to Help’
NASA Administrator and former Shift4 Payments Inc. (NYSE:FOUR) CEO Jared Isaacman has hailed Elon Musk-led Space Exploration Technologies Corp.‘s (NASDAQ:SPCX) successful Starship orbital launch on Monday. Jared Isaacman Calls Starship Launch ‘Inspirational’ Quoting a post by SpaceX on the social me...
09-29 13:37
美股大行评级 | Meta获4家机构齐升目标价，最高看至995美元！麦当劳遭6家机构下调，最低看至260美元
今日重点评级关注：Canaccord Genuity：维持Aurora Innovation"买入"评级，目标价从15美元升至17美元；摩根大通：维持皇家加勒比邮轮"超配"评级，目标价从345美元升至394美元
09-25 15:55
美股大行评级 | 麦当劳目标价遭下调至320美元！现价仍有近3成上涨空间；戴尔、迈威尔、微软齐获机构看好
今日重点评级关注：HC Wainwright & Co.：维持Gossamer Bio"买入"评级，目标价从2美元升至90美元；巴克莱：维持Ultragenyx Pharmaceutical"超配"评级，目标价从32美元升至35美元
09-22 16:25
StoneX Maintains Buy on Shift4 Payments, Lowers Price Target to $56
StoneX analyst Mark Palmer maintains Shift4 Payments (NYSE:FOUR) with a Buy and lowers the price target from $67 to $56.
09-21 20:41
美股大行评级 | Adobe绩后获多家大行齐升目标价！最高看多至270美元；甲骨文绩后现多空分歧
今日重点评级关注：Ascendiant Capital：维持Outlook Therapeutics"买入"评级，目标价从10美元升至10.5美元；摩根士丹利：维持Aurora Innovation"超配"评级，目标价从14美元升至18美元
09-14 16:05
RBC Capital Reiterates Outperform on Shift4 Payments, Maintains $67 Price Target
RBC Capital analyst Daniel R. Perlin reiterates Shift4 Payments (NYSE:FOUR) with a Outperform and maintains $67 price target.
09-11 22:04
美股大行评级 | 潜在涨幅1024.26%！Ascendiant Capital上调PAVmed目标价至57美元，维持"买入"评级
今日重点评级关注：Ascendiant Capital：维持PAVmed"买入"评级，目标价从56美元升至57美元；Ascendiant Capital：维持Lucid Diagnostics"买入"评级，目标价从9.25美元升至9.5美元
08-28 16:15
美股大行评级 | 瑞杰金融维持英伟达"强力买入"评级，目标价从330美元升至352美元；瑞穗下调美光科技目标价从1375美元降至1300美元
今日重点评级关注：摩根大通：维持Ultragenyx Pharmaceutical"超配"评级，目标价从75美元升至80美元；瑞杰金融：维持英伟达"强力买入"评级，目标价从330美元升至352美元
08-26 08:37
This AMD Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. UBS analyst Jon Windham upgraded Fluence Energy Inc (NASDAQ:FLNC) from Sell to Neutral and raised...
08-25 21:17
